ORIC Pharmaceuticals, Inc. (ORIC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 718.15M |
| Enterprise Value | 684.04M |
| P/E Ratio | -6.2 |
| PEG Ratio | -0.23 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.27 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -6.5 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.31 |
| Return On Equity | -0.35 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.22M |
| EBITDA | -128.25M |
| Net Income | -129.47M |
| Diluted EPS | -1.47 |
Balance Sheet
| Total Cash | 281.93M |
| Total Cash/Share | 2.67 |
| Total Debt | 3.3M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 16.33 |
| Book Value Per Share | 3.94 |
Price History
| 52-Week Change | -10.7 |
| 52-Week High | 14.93 |
| 52-Week Low | 7.23 |
| Moving Average 50 Days | 9.01 |
| Moving Average 200 Days | 10.69 |
Statistics
| Average Volume | 1.9M |
| Shares Outstanding | 103.52M |
| % Held by Institutions | 135.95 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
